Literature DB >> 622044

The renal vasculature in early essential hypertension: evidence for a pathogenetic role.

N K Hollenberg, L J Borucki, D F Adams.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 622044     DOI: 10.1097/00005792-197803000-00004

Source DB:  PubMed          Journal:  Medicine (Baltimore)        ISSN: 0025-7974            Impact factor:   1.889


× No keyword cloud information.
  11 in total

1.  Recent pathogenic aspects in essential hypertension and hypertension associated with diabetes mellitus.

Authors:  P Weidmann
Journal:  Klin Wochenschr       Date:  1980-10-01

2.  Effects of ACE inhibition on renal haemodynamics in essential hypertension and hypertension associated with chronic renal failure.

Authors:  R A Sánchez; C A Traballi; E J Marcó; B H Gilbert; A J Ramírez; G Long
Journal:  Drugs       Date:  1991       Impact factor: 9.546

3.  Studies with fenoldopam, a dopamine receptor DA1 agonist, in essential hypertension.

Authors:  J N Harvey; D P Worth; J Brown; M R Lee
Journal:  Br J Clin Pharmacol       Date:  1986-01       Impact factor: 4.335

Review 4.  Renal effects of antihypertensive drugs.

Authors:  W A Schlueter; D C Batlle
Journal:  Drugs       Date:  1989-06       Impact factor: 9.546

5.  Acute and chronic effects of lisinopril on renal and systemic hemodynamics in hypertension.

Authors:  J P Degaute; M Leeman; C Reuse; E Carlier; A Schoutens; P Vandepapeliere
Journal:  Cardiovasc Drugs Ther       Date:  1992-10       Impact factor: 3.727

Review 6.  Acute and chronic effects of angiotensin converting enzyme inhibitors on the essential hypertensive kidney.

Authors:  G P Reams; J H Bauer
Journal:  Cardiovasc Drugs Ther       Date:  1990-02       Impact factor: 3.727

7.  Impaired renal functional reserve and albuminuria in essential hypertension.

Authors:  A Losito; F Fortunati; I Zampi; A Del Favero
Journal:  Br Med J (Clin Res Ed)       Date:  1988-06-04

8.  Selective peripheral dopamine-1 receptor stimulation with fenoldopam in human essential hypertension.

Authors:  R M Carey; R M Stote; J W Dubb; L H Townsend; C E Rose; D L Kaiser
Journal:  J Clin Invest       Date:  1984-12       Impact factor: 14.808

9.  Effect of nifedipine and mefruside on renal reserve in hypertensive patients.

Authors:  A Notghi; J L Anderton
Journal:  Postgrad Med J       Date:  1988-11       Impact factor: 2.401

Review 10.  The kidney and arterial hypertension.

Authors:  L M Ruilope; C Campo; V Lahera
Journal:  Drugs       Date:  1993       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.